227 related articles for article (PubMed ID: 30047346)
41. Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting.
Fogel I; Ollech A; Zvulunov A; Valdman-Greenshpon Y; Atar Snir V; Friedland R; Lapidoth M; Ben-Amitai D
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):2004-2009. PubMed ID: 29573481
[TBL] [Abstract][Full Text] [Related]
42. Infantile haemangioma and β-blockers in otolaryngology.
Leboulanger N; Cox A; Garabedian EN; Denoyelle F
Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):236-40. PubMed ID: 21498145
[TBL] [Abstract][Full Text] [Related]
43. Monitoring propranolol treatment in periocular infantile haemangioma.
Burne R; Taylor R;
Eye (Lond); 2014 Nov; 28(11):1281-4; quiz 1285. PubMed ID: 25323853
[TBL] [Abstract][Full Text] [Related]
44. Use of propranolol for treatment of infantile haemangiomas in an outpatient setting.
Phillips RJ; Penington AJ; Bekhor PS; Crock CM
J Paediatr Child Health; 2012 Oct; 48(10):902-6. PubMed ID: 22897120
[TBL] [Abstract][Full Text] [Related]
45. Shouldn't Propranolol Be Used to Treat All Haemangiomas?
Moodley ST; Hudson DA; Adams S; Adams KG
Aesthetic Plast Surg; 2015 Dec; 39(6):963-7. PubMed ID: 26377820
[TBL] [Abstract][Full Text] [Related]
46. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
[TBL] [Abstract][Full Text] [Related]
47. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
48. News on infantile haemangioma. Part 2: therapy and evaluation.
Saerens J; De Leye H; Janmohamed SR
Clin Exp Dermatol; 2021 Apr; 46(3):480-486. PubMed ID: 33539606
[TBL] [Abstract][Full Text] [Related]
49. Initial experience with a multidisciplinary strategy for initiation of propranolol therapy for infantile hemangiomas.
Cushing SL; Boucek RJ; Manning SC; Sidbury R; Perkins JA
Otolaryngol Head Neck Surg; 2011 Jan; 144(1):78-84. PubMed ID: 21493392
[TBL] [Abstract][Full Text] [Related]
50. [Treatment of haemangiomas of infancy with propranolol; good results, few side effects].
Hermans DJ; Ottenhof MJ; Wijnen MH; van Beynum IM; van der Horst CM; van der Vleuten CJ
Ned Tijdschr Geneeskd; 2011; 155(40):A3482. PubMed ID: 21988755
[TBL] [Abstract][Full Text] [Related]
51. Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy.
Kleber CJ; Spiess A; Kleber JB; Hinz U; Holland-Cunz S; Weiss J
Eur J Pediatr; 2012 Jun; 171(6):941-6. PubMed ID: 22203431
[TBL] [Abstract][Full Text] [Related]
52. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
53. [Rapid regression of infantile haemangioma with 2% propranolol ointment].
Mouhari-Toure A; Azoumah KD; Tchamdja K; Saka B; Kombaté K; Tchangaï-Walla K; Pitche P
Ann Dermatol Venereol; 2013; 140(6-7):462-4. PubMed ID: 23773747
[TBL] [Abstract][Full Text] [Related]
54. Pathogenesis of infantile haemangioma.
Greenberger S; Bischoff J
Br J Dermatol; 2013 Jul; 169(1):12-9. PubMed ID: 23668474
[TBL] [Abstract][Full Text] [Related]
55. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
[TBL] [Abstract][Full Text] [Related]
56. The psychosocial impact of an infantile haemangioma on children and their parents.
Zweegers J; van der Vleuten CJ
Arch Dis Child; 2012 Oct; 97(10):922-6. PubMed ID: 22863688
[TBL] [Abstract][Full Text] [Related]
57. [Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma].
Rodríguez-Ruiz M; Tellado MG; del Pozo Losada J
An Pediatr (Barc); 2016 Feb; 84(2):92-6. PubMed ID: 26002439
[TBL] [Abstract][Full Text] [Related]
58. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
Storch CH; Hoeger PH
Br J Dermatol; 2010 Aug; 163(2):269-74. PubMed ID: 20456345
[TBL] [Abstract][Full Text] [Related]
59. Propranolol use for infantile hemangiomas: American Society of Pediatric Otolaryngology Vascular Anomalies Task Force practice patterns.
Parikh SR; Darrow DH; Grimmer JF; Manning SC; Richter GT; Perkins JA
JAMA Otolaryngol Head Neck Surg; 2013 Feb; 139(2):153-6. PubMed ID: 23429945
[TBL] [Abstract][Full Text] [Related]
60. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
